Page last updated: 2024-08-25

fangchinoline and Granulocytic Leukemia, Chronic

fangchinoline has been researched along with Granulocytic Leukemia, Chronic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ahn, KS; Alharbi, SA; Chinnathambi, A; Jung, YY; Sethi, G; Shair, OHM; Shanmugam, MK; Um, JY	1

Other Studies

1 other study(ies) available for fangchinoline and Granulocytic Leukemia, Chronic

Article	Year
Fangchinoline, a Bisbenzylisoquinoline Alkaloid can Modulate Cytokine-Impelled Apoptosis via the Dual Regulation of NF-κB and AP-1 Pathways. Molecules (Basel, Switzerland), 2019, Aug-28, Volume: 24, Issue:17 Topics: Benzylisoquinolines; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Screening Assays, Antitumor; Humans; I-kappa B Kinase; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Multiple Myeloma; NF-kappa B; Phosphorylation; Signal Transduction; Transcription Factor AP-1; Tumor Necrosis Factor-alpha	2019

Article

Year

Fangchinoline, a Bisbenzylisoquinoline Alkaloid can Modulate Cytokine-Impelled Apoptosis via the Dual Regulation of NF-κB and AP-1 Pathways.

Molecules (Basel, Switzerland), 2019, Aug-28, Volume: 24, Issue:17

Topics: Benzylisoquinolines; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Screening Assays, Antitumor; Humans; I-kappa B Kinase; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Multiple Myeloma; NF-kappa B; Phosphorylation; Signal Transduction; Transcription Factor AP-1; Tumor Necrosis Factor-alpha

2019